US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amicus Therapeutics

6.11

-0.0550-0.89%

Volume:1.99M

Turnover:12.20M

Market Cap:1.88B

PE:-63.51

High:6.20

Open:6.19

Low:6.07

Close:6.16

Loading ...

Overview Company News Filings

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

Calendar of U.S. Earnings Expected in the Week Ahead

Amicus Therapeutics Signs Exclusive License Deal for Dimerix Kidney Disease Therapy

MT Newswires Live

BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug

Guess which ASX All Ords stock is rocketing 58% on big US news

BRIEF-Dimerix And Amicus Therapeutics Announce Exclusive License Agreement For DMX-200 In United States

Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States

Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

TD Cowen Remains a Buy on Amicus (FOLD)

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025

4 Healthcare Stocks to Buy as the Sector Faces Government Heat

Bank of America Securities Reaffirms Their Buy Rating on Amicus (FOLD)

Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon

Simply Wall St.

BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo

5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

New Strong Buy Stocks for April 1st

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FOLD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FOLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FOLD\",,,,,undefined,":{"symbol":"FOLD","market":"US","secType":"STK","nameCN":"Amicus Therapeutics","latestPrice":6.105,"timestamp":1749487735185,"preClose":6.16,"halted":0,"volume":1992861,"delay":0,"floatShares":263984983,"shares":307930984,"eps":-0.096123,"marketStatus":"Trading","change":-0.055,"latestTime":"06-09 12:48:57 EDT","open":6.19,"high":6.2,"low":6.07,"amount":12199644.5721696,"amplitude":0.021104,"askPrice":6.11,"askSize":1206,"bidPrice":6.1,"bidSize":1405,"shortable":3,"etf":0,"ttmEps":-0.096123,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1749499200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1180584000000,"exchange":"NASDAQ","adjPreClose":6.16,"preHourTrading":{"tag":"盘前","latestPrice":6.21,"preClose":6.16,"latestTime":"09:29 EDT","volume":2397,"amount":14879.389485000002,"timestamp":1749475799999},"postHourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.16,"latestTime":"18:49 EDT","volume":65698,"amount":404757.85,"timestamp":1749250193969},"volumeRatio":0.874959,"impliedVol":0.4687,"impliedVolPercentile":0.772},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FOLD\",,,,,undefined,":{"symbol":"FOLD","floatShares":263984983,"roa":"3.95%","roe":"-18.12%","lyrEps":-0.184328,"volumeRatio":0.874959,"shares":307930984,"dividePrice":0,"high":6.2,"amplitude":0.021104,"preClose":6.16,"low":6.07,"week52Low":5.81,"pbRate":"9.71","psRate":"3.46","week52High":12.65,"institutionHeld":0,"latestPrice":6.105,"committee":0.076216,"eps":-0.096123,"divideRate":0,"volume":1992861,"delay":0,"ttmEps":-0.096123,"open":6.19,"prevYearClose":9.42,"prevWeekClose":6.16,"prevMonthClose":6.07,"prevQuarterClose":8.16,"fiveDayClose":6.16,"twentyDayClose":5.98,"sixtyDayClose":8.81},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FOLD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532730540","title":"Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2532730540","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532730540?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:00","pubTimestamp":1746097200,"startTime":"0","endTime":"0","summary":"1Q 2025 Total Revenue of $125.2M, a 15% Increase Year-over-Year at CER. Expanding Portfolio through In-Licensing of DMX-200 Phase 3 Program for Rare Kidney Disease with Significant Market Potential in the U.S.Maintaining 2025 Guidance for Galafold, Reflecting Strong Underlying Demand. Updating 2025 Pombiliti + Opfolda Guidance with New Patient Starts Accelerating in 2H. Adjusting 2025 Total Revenue Growth Guidance to 15-22% at CER. Galafold  net product sales for the first quarter 2025 were $104.2 million, representing a year-over-year increase of 5%, or 6% at CER1. Strong patient demand of 14% in the quarter was partially o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-announces-first-quarter-110000993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171402.SGD","LU2065170008.USD","FOLD","LU2065169927.USD","LU2065171311.SGD","BK4139"],"gpt_icon":0},{"id":"2532024224","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2532024224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532024224?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:00","pubTimestamp":1746093600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·A10 Networks Inc.                               1Q       .18    4:06 PM. ·Air Pdcts and Chem                               2Q      2.83    6:00 AM. ·Amer. Hms 4 Rent                                 1Q       .15        AMC. ·Applied Indus. Tech                              3Q      2.41    6:30 AM. ·Arthur J. Gallagher                              1Q      3.57    4:15 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMWL","DTE","APD","FOLD","APG","CTRE","ALKS","CWT","CLDX","FTV","BJRI","AMZN","ATI","CARR","APLS","CABO","ABNB","ALNY","AXTI","CUZ","AGIO","ESAB","FTDR","D","DRH","ULCC","CAH","GTLS","CODI","DBRG","FIVN","AAPL","AIG","OWL","ASND","CWST","AGCO","DSGR","EGO","DUOL","ES","COMM","CVS","AAON","ATR","TEAM","ALHC","ARW","BZH","ARVN"],"gpt_icon":1},{"id":"2532942029","title":"Amicus Therapeutics Signs Exclusive License Deal for Dimerix Kidney Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2532942029","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532942029?lang=en_us&edition=fundamental","pubTime":"2025-05-01 16:57","pubTimestamp":1746089859,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics  signed a license agreement to commercialize of Dimerix's DMX-200, a kidney disease therapy candidate for all indications, including Focal Segmental Glomerulosclerosis, or FSGS, the companies said Wednesday.In exchange for the US rights, Dimerix will receive a $30 million upfront payment, up to $560 million in milestone payments, and tiered royalties on US sales, according to the statement.DMX-200 is under a phase 3 study for the treatment of FSGS, with full enrollment for the study expected by the end of the year, the companies said.Dimerix will continue to fund and execute the phase 3 study, while Amicus will be in charge of the regulatory process and commercialization in the US. Amicus will have the exclusive rights to develop DMX-200 in other future indications in the US.Dimerix retains rights in other territories, according to the statement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD","LU2065169927.USD","BK4139","FOLD"],"gpt_icon":0},{"id":"2532049548","title":"BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2532049548","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532049548?lang=en_us&edition=fundamental","pubTime":"2025-05-01 12:23","pubTimestamp":1746073390,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug** Dimerix DXB.AX surges as much as 58.33% to A$0.760, highest since September 9, 2020** Stock marks biggest intraday pct gain since October 5, 2023** Biotech firm announces exclusive license agreement with Amicus Therapeutics FOLD.O to commercialise its Phase 3 drug candidate, DMX-200, in the U.S.** Says DMX-200 currently being developed to treat focal segmental glomerulosclerosis kidney disease** Stock sees busiest session since October 6, 2023, with more than 31 mln shares traded - 18.3x the 30-day avg** Last up 50%, DXB more than doubles YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4N3R909Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","FOLD","LU2065171311.SGD","BK7067","LU2065169927.USD","LU2065171402.SGD","BK7501","LU2065170008.USD","DXB.AU","BK4139"],"gpt_icon":0},{"id":"2532108840","title":"Guess which ASX All Ords stock is rocketing 58% on big US news","url":"https://stock-news.laohu8.com/highlight/detail?id=2532108840","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532108840?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:13","pubTimestamp":1746062011,"startTime":"0","endTime":"0","summary":"The share market may be struggling to get into gear on Thursday but that isn't stopping one ASX All Ords stock from racing higher. In morning trade, its shares are up a massive 58% to 76 cents thanks to some big news. Which ASX All Ords stock is rocketing?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/01/guess-which-asx-all-ords-stock-is-rocketing-58-on-big-us-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","LU2065170008.USD","BK4139","DXB.AU","FSGS","BK7501","LU2065169927.USD","LU2065171311.SGD","BK7067","FOLD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2532501587","title":"BRIEF-Dimerix And Amicus Therapeutics Announce Exclusive License Agreement For DMX-200 In United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2532501587","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532501587?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:15","pubTimestamp":1746054919,"startTime":"0","endTime":"0","summary":"BRIEF-Dimerix And Amicus Therapeutics Announce Exclusive License Agreement For DMX-200 In United StatesMay 1  - Dimerix Ltd DXB.AX:DIMERIX AND AMICUS THERAPEUTICS ANNOUNCE EXCLUSIVE LICENSE AGREEMENT FOR DMX-200 IN UNITED STATESDIMERIX TO RECEIVE US$30 MILLION UPFRONT PAYMENTDIMERIX TO RECEIVE UP TO US$560 MILLION FOR SUCCESS-BASED MILESTONE PAYMENTSFurther company coverage: DXB.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R8371:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4139","LU2065171402.SGD","LU2065171311.SGD","LU2065169927.USD","BK7508","BK7067","BK7501","DXB.AU","FOLD"],"gpt_icon":0},{"id":"2532601534","title":"Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2532601534","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532601534?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:12","pubTimestamp":1746054720,"startTime":"0","endTime":"0","summary":"Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatmentof Focal Segmental Glomerulosclerosis . DMX-200 is in a pivotal Phase 3 trial for FSGS, a rare and fatal kidney disease with no FDA-approved therapies. Dimerix successfully completed Type C meeting with the FDA in March 2025, aligning on proteinuria as the primary endpoint for approval. Dimerix to receive US$30 million  upfront payment, up to US$560 million  for success-based milestone payments, in addition to tiered royalties on DMX-200 net U.S. sales. “We are delighted to partner with Amicus in the United States. The Amicus team has a remarkable history of successfully delivering rare disease medicines to those in need. Their expertise and resources will be crucial to help achieve our mutual objective of commercializing this innovative treatment,” said Dr. Nina Webster, CEO and Managing Director of Dimerix. “I’m grateful to the dedicated Dimerix team, trial participants, and investigators for their contin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dimerix-amicus-therapeutics-announce-exclusive-231200447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DMX","BK4211","DXBO.AU","UBCP","FOLD","ARB","FSGS","DXB.AU","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BK4139","LU2065169927.USD"],"gpt_icon":0},{"id":"2531018752","title":"Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2531018752","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531018752?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:01","pubTimestamp":1745935293,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year decline in earnings on lower revenues when Y-mAbs Therapeutics, Inc.  reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of -46.7%.Revenues are expected to be $19.55 million, down 1.9% from the year-ago quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/earnings-preview-y-mabs-therapeutics-140133433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOLD","YMAB"],"gpt_icon":0},{"id":"2530957518","title":"Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2530957518","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530957518?lang=en_us&edition=fundamental","pubTime":"2025-04-24 22:01","pubTimestamp":1745503295,"startTime":"0","endTime":"0","summary":"The market expects Amicus Therapeutics  to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 1, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This pharmaceutical company is expected to post quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-year c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-fold-earnings-expected-140135788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOLD"],"gpt_icon":0},{"id":"2529553806","title":"Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529553806","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529553806?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:57","pubTimestamp":1745427465,"startTime":"0","endTime":"0","summary":"We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Amicus Therapeutics, Inc.  stands against other Guru stocks to invest in.Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet. All three major indexes closed last week in the red, with the Dow and NASDAQ both dipping over 2%, and the broader market down more than 1%. Even though markets remain closed on April 18 for Good Friday, the general consensus is that the worst of the trade war headlines might be dying down.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-inc-fold-among-165745256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOLD","USAW.SI","LU2065171402.SGD","LU2065170008.USD","PSQ","USJW.SI","SQQQ","TSYW.SI","BK4139","TQQQ","MNQmain","QID","NQmain","NVIW.SI","LU2065171311.SGD","LU2065169927.USD",".IXIC","QLD"],"gpt_icon":1},{"id":"2529104504","title":"TD Cowen Remains a Buy on Amicus (FOLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529104504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529104504?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:58","pubTimestamp":1745409492,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Amicus (FOLD – Research Report) today and set a price target of $20.00. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-remains-a-buy-on-amicus-fold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-remains-a-buy-on-amicus-fold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","BK4585","COWN","BK4566","BK4207","BK4139","BK4127","FOLD","LU2065171311.SGD","TD","LU2065169927.USD","LU2065170008.USD"],"gpt_icon":0},{"id":"2529874251","title":"Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874251?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:00","pubTimestamp":1745233200,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April 21, 2025  -- Amicus Therapeutics  today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2025.Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.Media:Amicus TherapeuticsDiana MooreHead of Global Corporate Affairs and Communications dmoore@a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-announce-first-quarter-110000646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065170008.USD","LU2065171402.SGD","FOLD","LU2065171311.SGD","LU2065169927.USD","BK4139"],"gpt_icon":0},{"id":"2528749353","title":"4 Healthcare Stocks to Buy as the Sector Faces Government Heat","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749353","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528749353?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:21","pubTimestamp":1744892460,"startTime":"0","endTime":"0","summary":"The U.S. healthcare sector is currently navigating a complex landscape characterized by technological innovation, policy shifts, financial pressures and evolving consumer expectations. While artificial intelligence  is being increasingly integrated into healthcare, especially in areas like medical imaging and diagnostics, the biotech sector is experiencing significant challenges due to policy uncertainties and budget cuts under the Trump administration.Healthcare has lagged the S&P 500 over the past two years, with investors showing real interest in mega-cap tech and growth stocks based on the AI boom. While a late-year rally in 2023 saw the sector staging a recovery, it did not stop healthcare from becoming one of the S&P 500’s worst-performing sectors in 2023 and 2024. The sector grew just 2.5% in 2024 compared with the benchmark index’s 23.3% jump. This year, till the end of March, the Health Care Select Sector SPDR rallied 6.5%. As a result, stocks like Bioventus Inc. BVS, Amicus T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-healthcare-stocks-buy-sector-122100065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065169927.USD","BK4550","BVS","RIGL","LU2065170008.USD",".SPX","SPY","BK4559","SSO","ESmain","BK4585","OEF","IVV","OEX","SH","BK4198","HCSG","SDS","BK4534","BK4185","ENSG","BK4504","LU2065171402.SGD","BK4139","VOO","BK4137","LU2065171311.SGD","BK4581","BK4588","FOLD"],"gpt_icon":1},{"id":"2528797443","title":"Bank of America Securities Reaffirms Their Buy Rating on Amicus (FOLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797443?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:58","pubTimestamp":1744887522,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Amicus (FOLD – Research Report) today and set a price target of $14.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-amicus-fold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-amicus-fold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FOLD"],"gpt_icon":0},{"id":"2526563511","title":"Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2526563511","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526563511?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:29","pubTimestamp":1744284555,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Amicus Therapeutics, Inc.'s  future prospects. Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The US$2.1b market-cap company announced a latest loss of US$56m on 31 December 2024 for its most recent financial year result. The most pressing concern for investors is Amicus Therapeutics' path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.Using a line of best fit, we calculated an average annual growth rate of 53%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-expect-amicus-therapeutics-inc-112915817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","TSYW.SI","BK4139","NDAQ","NQmain","LU2065170008.USD","BK4585","LU2065169927.USD","IE00BKPKM429.USD","SQQQ","BK4588","LU2210149790.SGD","IE00BGHQF748.EUR",".IXIC","QID","LU2210150020.SGD","TQQQ","USAW.SI","IE00B64PRP62.GBP","FOLD","MNQmain","BK4112","QLD","LU2065171311.SGD","LU2095319765.USD","USJW.SI","IE00B3QW5Z07.USD","LU2065171402.SGD","PSQ"],"gpt_icon":1},{"id":"2526131059","title":"BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2526131059","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526131059?lang=en_us&edition=fundamental","pubTime":"2025-04-10 01:44","pubTimestamp":1744220640,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb BMY announced that it has obtained FDA approval for the label expansion of Opdivo  plus Yervoy .The regulatory body approved Opdivo plus Yervoy as a first-line treatment of adult and pediatric patients  with unresectable or metastatic microsatellite instability-high  or mismatch repair deficient  colorectal cancer .Please note that Opdivo , as a single agent or in combination with Yervoy, was previously granted accelerated approval in MSI-H/dMMR CRC in adult and pediatric patients  who have progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.The latest FDA approval converts this second-line indication to full approval for Opdivo monotherapy and expands the indication for Opdivo plus Yervoy into the first-line setting.Shares of BMY have risen 7.9% in the past year against the industry’s decline of 20%.This randomized, multicenter, open-label study is evaluating Opdivo plus Yervoy compared to Opdivo alone or chemotherapy in patients with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmy-gets-fda-nod-label-174400443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","LU0225771236.USD","IE0002141913.USD","LU2065170008.USD","LU1559883803.SGD","IE00BJJMRZ35.SGD","LU2065169927.USD","LU0456855351.SGD","LU2065171311.SGD","IE00BSNM7G36.USD","LU1093756168.USD","BK4532","LU1032466523.USD","BK4139","ANIP","CRC","BK4559","IE00BFXG1179.USD","LU0868494617.USD","LU1323610961.USD","LU1585245621.USD","LU1868836757.USD","LU2125154935.USD","BK4585","BMY","LU1989771016.USD","LU0114720955.EUR","LU0306807586.USD","LU2065171402.SGD","LU2360032135.SGD","LU2242652126.USD","LU0321505868.SGD","LU1430594728.SGD","LU0266512127.USD","LU0096364046.USD","LU1261432733.SGD","LU1291159041.SGD","LU1670711040.USD","LU0061475181.USD","LU1718418525.SGD","BK4534","BK4588","LU1670711123.USD","LU0985481810.HKD","LU0321505439.SGD","IE00BFTCPJ56.SGD","LU2125154778.USD","FOLD","LU1670710661.SGD"],"gpt_icon":0},{"id":"2525207390","title":"5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525207390","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525207390?lang=en_us&edition=fundamental","pubTime":"2025-04-08 01:22","pubTimestamp":1744046520,"startTime":"0","endTime":"0","summary":"The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing geopolitical tension. While 2025 started on an encouraging note and strong quarterly results buoyed investor optimism, a likely overall slowdown does not bode well. Nonetheless, given the continuous need for innovative medical treatments, irrespective of the state of the economy, the dynamic biotech industry will continue to grab investors’ interest despite the inherent volatility and uncertain macroeconomic environment.M&A activity is likely to accelerate in 2025 under the Trump administration and expected deregulation. Pharma and biotech industry leaders consistently seek to expand their product portfolios and pipelines through strategic collaborations and acquisitions. While oncology and immuno-oncology companies have always been at the top of acquisition targets, the lucrative obesity sector and gene-editing space are in spotlight as of now.Biotech companies like Gilead","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-biotech-stocks-worth-adding-172200110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADMA","BK4550","IVV","BK4559","OEX","IE00BZ1G4Q59.USD","BK4588","LU0234570918.USD","LU1066053197.SGD","LU0889565916.HKD","LU1066051498.USD","SDS","VOO","BK4534","BK4581","KRYS","GILD","FOLD","LU2065171311.SGD","LU1839511570.USD","BK4585","LU0320765992.SGD","LU2468319806.SGD","IE00B3T34201.USD","BMRN","BK4578","SSO","SPY","LU0058720904.USD","BK4583","ESmain","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1571399168.USD","IE00BKVL7J92.USD","BK4532","LU2089984988.USD","LU1585245621.USD",".SPX","LU2065170008.USD","LU2065171402.SGD","BK4504","LU2065169927.USD","SH","OEF","BK4139","IE0002270589.USD"],"gpt_icon":1},{"id":"2524128774","title":"CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128774","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128774?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:50","pubTimestamp":1743519000,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from the phase III ROSELLA study, which evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.The ROSELLA study met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review .Per management, data from the ROSELLA study suggested that the combo of relacorilant plus nab-paclitaxel has the potential to become a new standard of care for patients with platinum-resistant ovarian cancer.Year to date, shares of Corcept have skyrocketed 126.7% against the industry’s decline of 1.9%.The phase III ROSELLA study evaluated relacorilant in combination with nab-paclitaxel for treating patients with recurrent, platinum-resistant ovarian cancer.Data from the same showed that treatment with relacorilant plus nab-paclitaxel reduced the risk of d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cort-shares-rise-relacorilant-combo-145000011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP","LU0566484027.USD","BK4532","LU1559883803.SGD","BK4007","CORT","FOLD","CTMX","LU2065170008.USD","OS","LU2065171311.SGD","LU2065171402.SGD","BK4097","BK4139","LU2065169927.USD"],"gpt_icon":0},{"id":"2524030115","title":"New Strong Buy Stocks for April 1st","url":"https://stock-news.laohu8.com/highlight/detail?id=2524030115","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524030115?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:55","pubTimestamp":1743504900,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. Affirm Holdings, Inc.AFRM: This payment network provider has seen the Zacks Consensus Estimate for its current year earnings increasing 84.4% over the last 60 days.Tokio Marine Holdings, Inc. TKOMY: This insurance and financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.7% over the last 60 days.Tokio Marine Holdings Inc. price-consensus-chart | Tokio Marine Holdings Inc. Quote. Amicus Therapeutics, Inc.FOLD: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.9% over the last 60 days.Amicus Therapeutics, Inc. price-consensus-chart | Amicus Therapeutics, Inc. Quote. 908 Devices Inc.MASS: This commercial-stage technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 28.1% over the last 60 days.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-april-1st-105500463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2065171311.SGD","BK4157","BK4227","LU2065171402.SGD","LU1670710588.SGD","BK4106","BK4548","FOLD","LU1670711123.USD","LU2065169927.USD","BK4202","MASS","LU2065170008.USD","BK4504","BK4585","VFC","TKOMY","LU1670711040.USD","BK4535","AFRM","BK4588","BK4107","LU1670710661.SGD"],"gpt_icon":0},{"id":"2521400231","title":"Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2521400231","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521400231?lang=en_us&edition=fundamental","pubTime":"2025-03-21 22:10","pubTimestamp":1742566203,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Is This 1 Momentum Stock a Screaming Buy Right Now?Different than value or growth investors, momentum-oriented investors live by the saying \"the trend is your friend.\" This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.Amicus Therapeutics, Inc.  : Free Stock Analysis Report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-1-momentum-stock-could-141003868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","FOLD","LU2065170008.USD","LU2065171402.SGD","BK4139","LU2065169927.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":93,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FOLD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-01","symbol":"FOLD","fiscalQuarterEnding":"2025/03","expectedEps":0.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-02-19","symbol":"FOLD","fiscalQuarterEnding":"2024/12","expectedEps":0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-11-06","symbol":"FOLD","fiscalQuarterEnding":"2024/09","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.04},{"market":"US","date":"2024-08-08","symbol":"FOLD","fiscalQuarterEnding":"2024/06","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":0.01},{"market":"US","date":"2024-05-09","symbol":"FOLD","fiscalQuarterEnding":"2024/03","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FOLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FOLD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4167,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4167,"analysts":12,"updateTime":1734062400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FOLD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FOLD","date":"2025-06-06","current":-62.481485,"percent":0.017073,"low":-69.924749,"twenty":-22.565249,"median":-13.886685,"eighty":-10.75514,"high":-6.462925,"avg":-18.00563,"sd":10.519586,"marketCap":1835268664},"quantilePoints":[{"date":"2020-06-12","current":-8.664466,"twenty":-13.260904,"median":-9.530444,"eighty":-7.174634,"marketCap":2816271924},{"date":"2020-06-19","current":-12.08903,"twenty":-13.153054,"median":-9.528554,"eighty":-7.174634,"marketCap":3929382145},{"date":"2020-06-26","current":-12.08903,"twenty":-13.04049,"median":-9.528554,"eighty":-7.174634,"marketCap":3929382145},{"date":"2020-07-02","current":-12.326847,"twenty":-13.012349,"median":-9.528554,"eighty":-7.174634,"marketCap":4006681466},{"date":"2020-07-10","current":-12.310993,"twenty":-12.975593,"median":-9.528554,"eighty":-7.174634,"marketCap":4001528178},{"date":"2020-07-17","current":-12.057321,"twenty":-12.793167,"median":-9.528554,"eighty":-7.174634,"marketCap":3919075569},{"date":"2020-07-24","current":-11.534124,"twenty":-12.658592,"median":-9.528554,"eighty":-7.174634,"marketCap":3749017063},{"date":"2020-07-31","current":-11.454852,"twenty":-12.589963,"median":-9.528554,"eighty":-7.174634,"marketCap":3723250623},{"date":"2020-08-07","current":-12.215866,"twenty":-12.515631,"median":-9.528554,"eighty":-7.174634,"marketCap":3970608450},{"date":"2020-08-14","current":-12.719534,"twenty":-12.515631,"median":-9.528554,"eighty":-7.174634,"marketCap":3726543499},{"date":"2020-08-21","current":-12.896194,"twenty":-12.515631,"median":-9.528554,"eighty":-7.174634,"marketCap":3778301047},{"date":"2020-08-28","current":-13.037522,"twenty":-12.515631,"median":-9.528554,"eighty":-7.174634,"marketCap":3819707086},{"date":"2020-09-04","current":-12.021726,"twenty":-12.486148,"median":-9.528554,"eighty":-7.174634,"marketCap":3522101182},{"date":"2020-09-11","current":-11.385749,"twenty":-12.449531,"median":-9.528554,"eighty":-7.174634,"marketCap":3335774007},{"date":"2020-09-18","current":-12.896194,"twenty":-12.38709,"median":-9.528554,"eighty":-7.174634,"marketCap":3778301047},{"date":"2020-09-25","current":-12.185136,"twenty":-12.337333,"median":-9.528554,"eighty":-7.174634,"marketCap":3569976914},{"date":"2020-10-02","current":-11.898064,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":3485870898},{"date":"2020-10-09","current":-13.351094,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":3911576735},{"date":"2020-10-16","current":-15.166277,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":4443385547},{"date":"2020-10-23","current":-16.323401,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":4782397490},{"date":"2020-10-30","current":-15.749256,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":4614185457},{"date":"2020-11-06","current":-18.071104,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5334228376},{"date":"2020-11-13","current":-19.404145,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5727715667},{"date":"2020-11-20","current":-19.404145,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5727715667},{"date":"2020-11-27","current":-20.516485,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6056056056},{"date":"2020-12-04","current":-20.463516,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6040420799},{"date":"2020-12-11","current":-19.510083,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5758986181},{"date":"2020-12-18","current":-21.160936,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6246285011},{"date":"2020-12-24","current":-21.390466,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6314037790},{"date":"2020-12-31","current":-20.384064,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6016967914},{"date":"2021-01-08","current":-20.437032,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":6032603171},{"date":"2021-01-15","current":-19.276138,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5689930464},{"date":"2021-01-22","current":-18.618445,"twenty":-12.331733,"median":-9.528554,"eighty":-7.174634,"marketCap":5495792694},{"date":"2021-01-29","current":-16.693921,"twenty":-12.332341,"median":-9.528554,"eighty":-7.174634,"marketCap":4927711705},{"date":"2021-02-05","current":-17.735636,"twenty":-12.337333,"median":-9.528554,"eighty":-7.174634,"marketCap":5235205084},{"date":"2021-02-12","current":-11.096911,"twenty":-12.367709,"median":-9.528554,"eighty":-7.174634,"marketCap":3275586257},{"date":"2021-02-19","current":-10.787928,"twenty":-12.34776,"median":-9.528554,"eighty":-7.174634,"marketCap":3184380594},{"date":"2021-02-26","current":-10.840897,"twenty":-12.326847,"median":-9.528554,"eighty":-7.174634,"marketCap":3200015850},{"date":"2021-03-05","current":-10.005463,"twenty":-12.296182,"median":-9.528344,"eighty":-7.174562,"marketCap":2770032455},{"date":"2021-03-12","current":-10.291879,"twenty":-12.229878,"median":-9.528344,"eighty":-7.174562,"marketCap":2849327277},{"date":"2021-03-19","current":-9.785878,"twenty":-12.185611,"median":-9.528344,"eighty":-7.174562,"marketCap":2709239758},{"date":"2021-03-26","current":-9.155762,"twenty":-12.169888,"median":-9.523779,"eighty":-7.174634,"marketCap":2534791149},{"date":"2021-04-01","current":-9.604481,"twenty":-12.108093,"median":-9.512358,"eighty":-7.174634,"marketCap":2659019704},{"date":"2021-04-09","current":-8.773875,"twenty":-12.059441,"median":-9.469868,"eighty":-7.174562,"marketCap":2429064720},{"date":"2021-04-16","current":-9.489914,"twenty":-12.023623,"median":-9.437777,"eighty":-7.174562,"marketCap":2627301775},{"date":"2021-04-23","current":-9.556745,"twenty":-11.976789,"median":-9.432831,"eighty":-7.174562,"marketCap":2645803900},{"date":"2021-04-30","current":-9.45626,"twenty":-11.952792,"median":-9.432831,"eighty":-7.174562,"marketCap":2617984614},{"date":"2021-05-07","current":-9.36977,"twenty":-11.951808,"median":-9.406353,"eighty":-7.174562,"marketCap":2594039633},{"date":"2021-05-14","current":-9.957541,"twenty":-11.951808,"median":-9.406353,"eighty":-7.174562,"marketCap":2524913717},{"date":"2021-05-21","current":-9.40143,"twenty":-11.951808,"median":-9.40143,"eighty":-7.174562,"marketCap":2383901676},{"date":"2021-05-28","current":-9.71621,"twenty":-11.951808,"median":-9.39715,"eighty":-7.174562,"marketCap":2463719813},{"date":"2021-06-04","current":-9.947048,"twenty":-11.942246,"median":-9.39715,"eighty":-7.174562,"marketCap":2522253113},{"date":"2021-06-11","current":-11.143212,"twenty":-11.942246,"median":-9.39715,"eighty":-7.174562,"marketCap":2825562032},{"date":"2021-06-18","current":-10.419218,"twenty":-11.942246,"median":-9.40143,"eighty":-7.174562,"marketCap":2641980318},{"date":"2021-06-25","current":-10.891388,"twenty":-11.942246,"median":-9.40143,"eighty":-7.174562,"marketCap":2761707522},{"date":"2021-07-02","current":-10.167394,"twenty":-11.942246,"median":-9.431054,"eighty":-7.174562,"marketCap":2578125808},{"date":"2021-07-09","current":-10.093946,"twenty":-11.942246,"median":-9.432631,"eighty":-7.174562,"marketCap":2559501577},{"date":"2021-07-16","current":-9.75818,"twenty":-11.942246,"median":-9.431054,"eighty":-7.174562,"marketCap":2474362231},{"date":"2021-07-23","current":-9.254532,"twenty":-11.942246,"median":-9.422415,"eighty":-7.174562,"marketCap":2346653213},{"date":"2021-07-30","current":-9.747688,"twenty":-11.930684,"median":-9.40143,"eighty":-7.174562,"marketCap":2471701626},{"date":"2021-08-06","current":-11.09322,"twenty":-11.92336,"median":-9.40143,"eighty":-7.174562,"marketCap":2798830377},{"date":"2021-08-13","current":-11.07209,"twenty":-11.922558,"median":-9.40143,"eighty":-7.174562,"marketCap":2793499271},{"date":"2021-08-20","current":-11.135479,"twenty":-11.922558,"median":-9.40143,"eighty":-7.174562,"marketCap":2809492587},{"date":"2021-08-27","current":-11.896157,"twenty":-11.922558,"median":-9.40143,"eighty":-7.174562,"marketCap":3001412385},{"date":"2021-09-03","current":-12.287061,"twenty":-11.951808,"median":-9.40143,"eighty":-7.174562,"marketCap":3100037836},{"date":"2021-09-10","current":-11.547513,"twenty":-11.969286,"median":-9.40143,"eighty":-7.174562,"marketCap":2913449144},{"date":"2021-09-17","current":-11.621468,"twenty":-11.969286,"median":-9.40143,"eighty":-7.174562,"marketCap":2932108014},{"date":"2021-09-24","current":-11.484123,"twenty":-11.931702,"median":-9.40143,"eighty":-7.174562,"marketCap":2897455828},{"date":"2021-10-01","current":-10.795265,"twenty":-11.92336,"median":-9.40143,"eighty":-7.174562,"marketCap":2723656190},{"date":"2021-10-08","current":-12.19367,"twenty":-11.92336,"median":-9.40143,"eighty":-7.174562,"marketCap":3076475246},{"date":"2021-10-15","current":-11.738129,"twenty":-11.931702,"median":-9.40143,"eighty":-7.174562,"marketCap":2961541766},{"date":"2021-10-22","current":-11.123679,"twenty":-11.925628,"median":-9.40143,"eighty":-7.174562,"marketCap":2806515211},{"date":"2021-10-29","current":-11.123679,"twenty":-11.92336,"median":-9.40143,"eighty":-7.174562,"marketCap":2806515211},{"date":"2021-11-05","current":-12.765745,"twenty":-11.969286,"median":-9.406353,"eighty":-7.174562,"marketCap":3220810314},{"date":"2021-11-12","current":-13.244155,"twenty":-11.992573,"median":-9.406353,"eighty":-7.174562,"marketCap":3159843451},{"date":"2021-11-19","current":-13.244155,"twenty":-12.029282,"median":-9.406353,"eighty":-7.174562,"marketCap":3159843451},{"date":"2021-11-26","current":-12.613481,"twenty":-12.057321,"median":-9.406353,"eighty":-7.174562,"marketCap":3009374715},{"date":"2021-12-03","current":-12.204711,"twenty":-12.110622,"median":-9.432631,"eighty":-7.174562,"marketCap":2911848683},{"date":"2021-12-10","current":-12.006165,"twenty":-12.169975,"median":-9.45626,"eighty":-7.174562,"marketCap":2864478895},{"date":"2021-12-17","current":-12.660197,"twenty":-12.180194,"median":-9.495864,"eighty":-7.179474,"marketCap":3020520547},{"date":"2021-12-23","current":-14.225203,"twenty":-12.187616,"median":-9.51245,"eighty":-7.199819,"marketCap":3393905929},{"date":"2021-12-31","current":-13.489417,"twenty":-12.21111,"median":-9.525505,"eighty":-7.210612,"marketCap":3218359070},{"date":"2022-01-07","current":-13.325909,"twenty":-12.287287,"median":-9.533275,"eighty":-7.213326,"marketCap":3179348657},{"date":"2022-01-14","current":-12.298144,"twenty":-12.289662,"median":-9.563458,"eighty":-7.213974,"marketCap":2934140347},{"date":"2022-01-21","current":-10.499555,"twenty":-12.289662,"median":-9.580498,"eighty":-7.23118,"marketCap":2505025804},{"date":"2022-01-28","current":-10.663063,"twenty":-12.289662,"median":-9.598011,"eighty":-7.248697,"marketCap":2544036217},{"date":"2022-02-04","current":-10.534592,"twenty":-12.289662,"median":-9.623829,"eighty":-7.27623,"marketCap":2513385179},{"date":"2022-02-11","current":-10.604667,"twenty":-12.289662,"median":-9.641652,"eighty":-7.27623,"marketCap":2530103927},{"date":"2022-02-18","current":-10.324368,"twenty":-12.289662,"median":-9.65559,"eighty":-7.27623,"marketCap":2463228933},{"date":"2022-02-25","current":-9.224498,"twenty":-12.289662,"median":-9.655924,"eighty":-7.27623,"marketCap":2310367834},{"date":"2022-03-04","current":-8.821975,"twenty":-12.289662,"median":-9.654312,"eighty":-7.27623,"marketCap":2209551783},{"date":"2022-03-11","current":-10.387344,"twenty":-12.289662,"median":-9.654312,"eighty":-7.27623,"marketCap":2601614203},{"date":"2022-03-18","current":-11.259478,"twenty":-12.289662,"median":-9.65983,"eighty":-7.27623,"marketCap":2820048981},{"date":"2022-03-25","current":-10.44325,"twenty":-12.289662,"median":-9.673889,"eighty":-7.27623,"marketCap":2615616433},{"date":"2022-04-01","current":-10.543881,"twenty":-12.289662,"median":-9.693109,"eighty":-7.27623,"marketCap":2640820445},{"date":"2022-04-08","current":-9.761196,"twenty":-12.289662,"median":-9.702812,"eighty":-7.27623,"marketCap":2444789235},{"date":"2022-04-14","current":-9.157411,"twenty":-12.289662,"median":-9.702812,"eighty":-7.27623,"marketCap":2293565159},{"date":"2022-04-22","current":-8.754887,"twenty":-12.289662,"median":-9.702812,"eighty":-7.27623,"marketCap":2192749108},{"date":"2022-04-29","current":-7.919354,"twenty":-12.289662,"median":-9.695867,"eighty":-7.27623,"marketCap":1983481526},{"date":"2022-05-06","current":-7.013327,"twenty":-12.289662,"median":-9.687863,"eighty":-7.267765,"marketCap":1756557792},{"date":"2022-05-13","current":-7.770307,"twenty":-12.289662,"median":-9.687863,"eighty":-7.27623,"marketCap":2098418016},{"date":"2022-05-20","current":-8.050411,"twenty":-12.289662,"median":-9.687863,"eighty":-7.286409,"marketCap":2174061923},{"date":"2022-05-27","current":-8.247522,"twenty":-12.289662,"median":-9.687863,"eighty":-7.286409,"marketCap":2227292821},{"date":"2022-06-03","current":-8.496504,"twenty":-12.289662,"median":-9.687863,"eighty":-7.289808,"marketCap":2294531849},{"date":"2022-06-10","current":-8.662492,"twenty":-12.289662,"median":-9.687863,"eighty":-7.289808,"marketCap":2339357868},{"date":"2022-06-17","current":-9.699916,"twenty":-12.289662,"median":-9.693109,"eighty":-7.289808,"marketCap":2619520487},{"date":"2022-06-24","current":-11.536157,"twenty":-12.291134,"median":-9.69986,"eighty":-7.289328,"marketCap":3115408323},{"date":"2022-07-01","current":-11.204181,"twenty":-12.291134,"median":-9.713021,"eighty":-7.289328,"marketCap":3025756285},{"date":"2022-07-08","current":-11.795513,"twenty":-12.291134,"median":-9.718788,"eighty":-7.289328,"marketCap":3185448978},{"date":"2022-07-15","current":-11.256052,"twenty":-12.281416,"median":-9.728594,"eighty":-7.289328,"marketCap":3039764416},{"date":"2022-07-22","current":-10.612849,"twenty":-12.204443,"median":-9.728594,"eighty":-7.289328,"marketCap":2866063592},{"date":"2022-07-29","current":-10.332745,"twenty":-12.180973,"median":-9.728594,"eighty":-7.289328,"marketCap":2790419685},{"date":"2022-08-05","current":-12.15878,"twenty":-12.165154,"median":-9.728594,"eighty":-7.289328,"marketCap":3416471254},{"date":"2022-08-12","current":-12.298536,"twenty":-12.173981,"median":-9.728594,"eighty":-7.289328,"marketCap":3455741039},{"date":"2022-08-19","current":-11.829355,"twenty":-12.177676,"median":-9.728594,"eighty":-7.289328,"marketCap":3323906762},{"date":"2022-08-26","current":-11.280313,"twenty":-12.177676,"median":-9.728594,"eighty":-7.289328,"marketCap":3169632609},{"date":"2022-09-02","current":-11.440034,"twenty":-12.159988,"median":-9.728594,"eighty":-7.289328,"marketCap":3214512363},{"date":"2022-09-09","current":-11.400104,"twenty":-12.098453,"median":-9.728594,"eighty":-7.289328,"marketCap":3203292424},{"date":"2022-09-16","current":-10.601498,"twenty":-12.057321,"median":-9.728594,"eighty":-7.289328,"marketCap":2978893655},{"date":"2022-09-23","current":-10.072421,"twenty":-12.033502,"median":-9.728594,"eighty":-7.289328,"marketCap":2830229471},{"date":"2022-09-30","current":-10.421811,"twenty":-12.007315,"median":-9.728594,"eighty":-7.289328,"marketCap":2928403932},{"date":"2022-10-07","current":-10.381881,"twenty":-11.971007,"median":-9.728594,"eighty":-7.289328,"marketCap":2917183994},{"date":"2022-10-14","current":-10.581533,"twenty":-11.931702,"median":-9.728594,"eighty":-7.289328,"marketCap":2973283686},{"date":"2022-10-21","current":-11.090644,"twenty":-11.907191,"median":-9.728594,"eighty":-7.289328,"marketCap":3116337901},{"date":"2022-10-28","current":-10.731271,"twenty":-11.887731,"median":-9.728594,"eighty":-7.289328,"marketCap":3015358455},{"date":"2022-11-04","current":-10.092386,"twenty":-11.83273,"median":-9.728594,"eighty":-7.289328,"marketCap":2835839440},{"date":"2022-11-11","current":-11.95172,"twenty":-11.828531,"median":-9.728594,"eighty":-7.289328,"marketCap":3155015123},{"date":"2022-11-18","current":-11.600512,"twenty":-11.830004,"median":-9.728594,"eighty":-7.289328,"marketCap":3062303192},{"date":"2022-11-25","current":-12.22843,"twenty":-11.83273,"median":-9.728594,"eighty":-7.289328,"marketCap":3228060888},{"date":"2022-12-02","current":-13.516193,"twenty":-11.83273,"median":-9.728594,"eighty":-7.289328,"marketCap":3568004636},{"date":"2022-12-09","current":-12.441283,"twenty":-11.89692,"median":-9.728594,"eighty":-7.289328,"marketCap":3284249937},{"date":"2022-12-16","current":-13.015987,"twenty":-11.922558,"median":-9.728594,"eighty":-7.289328,"marketCap":3435960370},{"date":"2022-12-23","current":-12.419998,"twenty":-11.922558,"median":-9.728594,"eighty":-7.289328,"marketCap":3278631032},{"date":"2022-12-30","current":-12.994702,"twenty":-11.922558,"median":-9.728594,"eighty":-7.289328,"marketCap":3430341465},{"date":"2023-01-06","current":-12.537067,"twenty":-11.952739,"median":-9.75818,"eighty":-7.289328,"marketCap":3309535009},{"date":"2023-01-13","current":-13.654548,"twenty":-11.989922,"median":-9.766211,"eighty":-7.289328,"marketCap":3604527519},{"date":"2023-01-20","current":-13.867401,"twenty":-12.02425,"median":-9.785878,"eighty":-7.289328,"marketCap":3660716568},{"date":"2023-01-27","current":-13.654548,"twenty":-12.038989,"median":-9.791988,"eighty":-7.289328,"marketCap":3604527519},{"date":"2023-02-03","current":-14.10154,"twenty":-12.08903,"median":-9.81173,"eighty":-7.289328,"marketCap":3722524522},{"date":"2023-02-10","current":-13.388481,"twenty":-12.16049,"median":-9.831629,"eighty":-7.289328,"marketCap":3534291207},{"date":"2023-02-17","current":-14.165396,"twenty":-12.178026,"median":-9.852614,"eighty":-7.289328,"marketCap":3739381237},{"date":"2023-02-24","current":-13.760974,"twenty":-12.187337,"median":-9.852614,"eighty":-7.289328,"marketCap":3632622043},{"date":"2023-03-03","current":-15.057851,"twenty":-12.207462,"median":-9.863107,"eighty":-7.289328,"marketCap":3562205698},{"date":"2023-03-10","current":-13.671573,"twenty":-12.222577,"median":-9.879101,"eighty":-7.289328,"marketCap":3234256602},{"date":"2023-03-17","current":-13.432559,"twenty":-12.286854,"median":-9.889223,"eighty":-7.289328,"marketCap":3177713655},{"date":"2023-03-24","current":-13.2772,"twenty":-12.303519,"median":-9.929085,"eighty":-7.289328,"marketCap":3140960739},{"date":"2023-03-31","current":-13.253299,"twenty":-12.328433,"median":-9.967654,"eighty":-7.289808,"marketCap":3135306444},{"date":"2023-04-06","current":-13.217447,"twenty":-12.348469,"median":-9.99263,"eighty":-7.289808,"marketCap":3126825002},{"date":"2023-04-14","current":-13.850833,"twenty":-12.419998,"median":-10.012526,"eighty":-7.289328,"marketCap":3276663813},{"date":"2023-04-21","current":-13.773584,"twenty":-12.438015,"median":-10.061232,"eighty":-7.289328,"marketCap":3258389219},{"date":"2023-04-28","current":-13.653814,"twenty":-12.489827,"median":-10.082404,"eighty":-7.289328,"marketCap":3230055400},{"date":"2023-05-05","current":-14.19278,"twenty":-12.525719,"median":-10.102308,"eighty":-7.289328,"marketCap":3357557587},{"date":"2023-05-12","current":-16.203438,"twenty":-12.54815,"median":-10.16086,"eighty":-7.289328,"marketCap":3309390094},{"date":"2023-05-19","current":-16.037339,"twenty":-12.615061,"median":-10.167394,"eighty":-7.289328,"marketCap":3275466145},{"date":"2023-05-26","current":-15.521803,"twenty":-12.678934,"median":-10.167394,"eighty":-7.289328,"marketCap":3170173142},{"date":"2023-06-02","current":-15.870138,"twenty":-12.698771,"median":-10.167394,"eighty":-7.289328,"marketCap":3241317063},{"date":"2023-06-09","current":-17.583946,"twenty":-12.739278,"median":-10.167394,"eighty":-7.289328,"marketCap":3591345157},{"date":"2023-06-16","current":-18.057682,"twenty":-12.86699,"median":-10.167394,"eighty":-7.289328,"marketCap":3688100890},{"date":"2023-06-23","current":-17.611813,"twenty":-12.896194,"median":-10.164127,"eighty":-7.288847,"marketCap":3597036671},{"date":"2023-06-30","current":-17.514279,"twenty":-12.942126,"median":-10.16086,"eighty":-7.288367,"marketCap":3577116373},{"date":"2023-07-07","current":-16.85941,"twenty":-12.9909,"median":-10.16086,"eighty":-7.288367,"marketCap":3443365800},{"date":"2023-07-14","current":-18.210949,"twenty":-13.037472,"median":-10.16086,"eighty":-7.288367,"marketCap":3719404216},{"date":"2023-07-21","current":-19.11662,"twenty":-13.072123,"median":-10.16086,"eighty":-7.288367,"marketCap":3904378411},{"date":"2023-07-28","current":-18.46175,"twenty":-13.136707,"median":-10.167394,"eighty":-7.288367,"marketCap":3770627839},{"date":"2023-08-04","current":-18.670751,"twenty":-13.177132,"median":-10.22216,"eighty":-7.288367,"marketCap":3813314192},{"date":"2023-08-11","current":-20.575593,"twenty":-13.220277,"median":-10.291879,"eighty":-7.288367,"marketCap":3812966043},{"date":"2023-08-18","current":-19.785416,"twenty":-13.244155,"median":-10.332745,"eighty":-7.288367,"marketCap":3666534365},{"date":"2023-08-25","current":-19.645973,"twenty":-13.27242,"median":-10.3538,"eighty":-7.288367,"marketCap":3640693481},{"date":"2023-09-01","current":-19.862884,"twenty":-13.378024,"median":-10.377248,"eighty":-7.288367,"marketCap":3680890412},{"date":"2023-09-08","current":-19.150176,"twenty":-13.395062,"median":-10.403288,"eighty":-7.288367,"marketCap":3548814781},{"date":"2023-09-15","current":-20.312201,"twenty":-13.440672,"median":-10.428275,"eighty":-7.288367,"marketCap":3764155484},{"date":"2023-09-22","current":-18.91777,"twenty":-13.48413,"median":-10.476794,"eighty":-7.288367,"marketCap":3505746640},{"date":"2023-09-29","current":-18.375492,"twenty":-13.562752,"median":-10.501672,"eighty":-7.288367,"marketCap":3405254312},{"date":"2023-10-06","current":-17.473118,"twenty":-13.641246,"median":-10.534592,"eighty":-7.287887,"marketCap":3238030836},{"date":"2023-10-12","current":-17.049622,"twenty":-13.654548,"median":-10.559983,"eighty":-7.287887,"marketCap":3159550735},{"date":"2023-10-20","current":-16.139891,"twenty":-13.691923,"median":-10.588606,"eighty":-7.286409,"marketCap":2990963851},{"date":"2023-10-27","current":-17.033937,"twenty":-13.727801,"median":-10.6175,"eighty":-7.291286,"marketCap":3156644065},{"date":"2023-11-03","current":-17.143732,"twenty":-13.815409,"median":-10.658543,"eighty":-7.304559,"marketCap":3176990758},{"date":"2023-11-10","current":-16.849895,"twenty":-13.849756,"median":-10.683414,"eighty":-7.337897,"marketCap":2925242944},{"date":"2023-11-17","current":-17.905653,"twenty":-13.878044,"median":-10.706913,"eighty":-7.425443,"marketCap":3108528842},{"date":"2023-11-24","current":-17.888761,"twenty":-13.897201,"median":-10.732204,"eighty":-7.476078,"marketCap":3105596268},{"date":"2023-12-01","current":-18.615123,"twenty":-13.981845,"median":-10.755732,"eighty":-7.514643,"marketCap":3231696966},{"date":"2023-12-08","current":-19.375268,"twenty":-14.022784,"median":-10.768175,"eighty":-7.533051,"marketCap":3363662813},{"date":"2023-12-15","current":-21.030697,"twenty":-14.126685,"median":-10.7974,"eighty":-7.565068,"marketCap":3651055103},{"date":"2023-12-22","current":-22.230037,"twenty":-14.225203,"median":-10.823411,"eighty":-7.588414,"marketCap":3859267884},{"date":"2023-12-29","current":-24.527367,"twenty":-14.252239,"median":-10.846071,"eighty":-7.657647,"marketCap":4258097999},{"date":"2024-01-05","current":-22.703017,"twenty":-14.444298,"median":-10.890499,"eighty":-7.672238,"marketCap":3941379966},{"date":"2024-01-12","current":-22.550988,"twenty":-14.552091,"median":-10.930923,"eighty":-7.697687,"marketCap":3914986797},{"date":"2024-01-19","current":-20.98002,"twenty":-14.874043,"median":-10.971723,"eighty":-7.7321,"marketCap":3642257379},{"date":"2024-01-26","current":-21.351647,"twenty":-15.153456,"median":-11.027793,"eighty":-7.759933,"marketCap":3706774016},{"date":"2024-02-02","current":-21.402323,"twenty":-15.537543,"median":-11.063807,"eighty":-7.805283,"marketCap":3715571739},{"date":"2024-02-09","current":-22.517204,"twenty":-15.689004,"median":-11.095191,"eighty":-7.874049,"marketCap":3909121648},{"date":"2024-02-16","current":-23.648976,"twenty":-16.06471,"median":-11.110813,"eighty":-7.923545,"marketCap":4105604132},{"date":"2024-02-23","current":-22.635448,"twenty":-16.203438,"median":-11.135479,"eighty":-7.967893,"marketCap":3929649669},{"date":"2024-03-01","current":-24.83031,"twenty":-16.374481,"median":-11.144866,"eighty":-8.007885,"marketCap":3763877759},{"date":"2024-03-08","current":-23.948783,"twenty":-16.563087,"median":-11.176969,"eighty":-8.007885,"marketCap":3630252326},{"date":"2024-03-15","current":-22.487303,"twenty":-16.748752,"median":-11.220499,"eighty":-8.007885,"marketCap":3408715365},{"date":"2024-03-22","current":-22.779599,"twenty":-16.843438,"median":-11.257812,"eighty":-8.007885,"marketCap":3453022757},{"date":"2024-03-28","current":-23.110868,"twenty":-16.908457,"median":-11.299305,"eighty":-8.007885,"marketCap":3503237802},{"date":"2024-04-05","current":-22.331412,"twenty":-16.998743,"median":-11.340209,"eighty":-8.00485,"marketCap":3385084756},{"date":"2024-04-12","current":-21.863738,"twenty":-17.096677,"median":-11.399122,"eighty":-8.00485,"marketCap":3314192929},{"date":"2024-04-19","current":-20.129449,"twenty":-17.138077,"median":-11.440034,"eighty":-8.00485,"marketCap":3051302402},{"date":"2024-04-26","current":-19.870924,"twenty":-17.265691,"median":-11.466069,"eighty":-8.007885,"marketCap":3012114181},{"date":"2024-05-03","current":-20.378932,"twenty":-17.420345,"median":-11.507797,"eighty":-8.007885,"marketCap":3089120050},{"date":"2024-05-10","current":-19.091136,"twenty":-17.506047,"median":-11.538009,"eighty":-8.030832,"marketCap":2807752452},{"date":"2024-05-17","current":-19.132869,"twenty":-17.606391,"median":-11.589779,"eighty":-8.109807,"marketCap":2813890148},{"date":"2024-05-24","current":-19.072449,"twenty":-17.764712,"median":-11.608776,"eighty":-8.200399,"marketCap":2805004179},{"date":"2024-05-31","current":-19.898184,"twenty":-17.850057,"median":-11.658804,"eighty":-8.247771,"marketCap":2926445754},{"date":"2024-06-07","current":-20.683638,"twenty":-17.986735,"median":-11.707255,"eighty":-8.496504,"marketCap":3041963350},{"date":"2024-06-14","current":-21.438883,"twenty":-18.071104,"median":-11.727118,"eighty":-8.61481,"marketCap":3153037961},{"date":"2024-06-21","current":-19.737065,"twenty":-18.175927,"median":-11.782445,"eighty":-8.716376,"marketCap":2902749837},{"date":"2024-06-28","current":-19.958603,"twenty":-18.203712,"median":-11.829355,"eighty":-8.75684,"marketCap":2935331723},{"date":"2024-07-05","current":-19.757205,"twenty":-18.29455,"median":-11.896157,"eighty":-8.791133,"marketCap":2905711827},{"date":"2024-07-12","current":-21.126715,"twenty":-18.531219,"median":-11.922558,"eighty":-8.851919,"marketCap":3107127121},{"date":"2024-07-15","current":-20.965596,"twenty":-18.531417,"median":-11.922558,"eighty":-8.860208,"marketCap":3083431204},{"date":"2024-08-02","current":-20.542659,"twenty":-18.601084,"median":-11.974608,"eighty":-9.099715,"marketCap":3021229422},{"date":"2024-08-09","current":-28.071668,"twenty":-18.657645,"median":-12.024578,"eighty":-9.156751,"marketCap":3355574887},{"date":"2024-08-16","current":-28.409568,"twenty":-18.719275,"median":-12.038989,"eighty":-9.205103,"marketCap":3395966159},{"date":"2024-08-23","current":-29.029865,"twenty":-18.868021,"median":-12.08903,"eighty":-9.235498,"marketCap":3470113892},{"date":"2024-08-30","current":-28.037391,"twenty":-18.954333,"median":-12.160917,"eighty":-9.265025,"marketCap":3351477520},{"date":"2024-09-06","current":-29.005053,"twenty":-19.004778,"median":-12.174356,"eighty":-9.317022,"marketCap":3467147983},{"date":"2024-09-13","current":-27.987767,"twenty":-19.10826,"median":-12.187706,"eighty":-9.366687,"marketCap":3345545701},{"date":"2024-09-20","current":-27.293035,"twenty":-19.204707,"median":-12.207541,"eighty":-9.422816,"marketCap":3262500241},{"date":"2024-09-27","current":-26.598303,"twenty":-19.281435,"median":-12.223553,"eighty":-9.454446,"marketCap":3179454780},{"date":"2024-10-04","current":-26.201314,"twenty":-19.328957,"median":-12.286888,"eighty":-9.500763,"marketCap":3132000231},{"date":"2024-10-11","current":-24.935909,"twenty":-19.42453,"median":-12.304765,"eighty":-9.568855,"marketCap":2980738856},{"date":"2024-10-18","current":-29.699785,"twenty":-19.51374,"median":-12.330811,"eighty":-9.603005,"marketCap":3550193444},{"date":"2024-10-25","current":-29.178736,"twenty":-19.602076,"median":-12.355861,"eighty":-9.639823,"marketCap":3487909348},{"date":"2024-10-31","current":-28.732122,"twenty":-19.658242,"median":-12.419998,"eighty":-9.662684,"marketCap":3434522980},{"date":"2024-11-08","current":-31.33967,"twenty":-19.737065,"median":-12.438294,"eighty":-9.699931,"marketCap":3280887387},{"date":"2024-11-15","current":-28.799387,"twenty":-19.777688,"median":-12.508369,"eighty":-9.751885,"marketCap":3014950249},{"date":"2024-11-22","current":-27.115379,"twenty":-19.867708,"median":-12.537067,"eighty":-9.789658,"marketCap":2838654843},{"date":"2024-11-29","current":-28.48542,"twenty":-19.934155,"median":-12.54771,"eighty":-9.852614,"marketCap":2982081614},{"date":"2024-12-06","current":-27.857485,"twenty":-19.963337,"median":-12.613481,"eighty":-9.875093,"marketCap":2916344344},{"date":"2024-12-13","current":-28.970642,"twenty":-19.98682,"median":-12.675422,"eighty":-9.917996,"marketCap":3032878595},{"date":"2024-12-20","current":-27.771857,"twenty":-20.020876,"median":-12.701868,"eighty":-9.967578,"marketCap":2907380171},{"date":"2024-12-27","current":-27.886027,"twenty":-20.089983,"median":-12.739278,"eighty":-9.991908,"marketCap":2919332402},{"date":"2025-01-03","current":-26.573072,"twenty":-20.135697,"median":-12.803134,"eighty":-10.006151,"marketCap":2781881746},{"date":"2025-01-10","current":-27.001209,"twenty":-20.202523,"median":-12.891777,"eighty":-10.051731,"marketCap":2826702612},{"date":"2025-01-17","current":-26.715784,"twenty":-20.249426,"median":-12.931526,"eighty":-10.075897,"marketCap":2796822035},{"date":"2025-01-24","current":-27.543517,"twenty":-20.309957,"median":-12.985197,"eighty":-10.094483,"marketCap":2883475709},{"date":"2025-01-31","current":-27.514975,"twenty":-20.377981,"median":-13.037398,"eighty":-10.157694,"marketCap":2880487651},{"date":"2025-02-07","current":-28.057282,"twenty":-20.4178,"median":-13.071027,"eighty":-10.186696,"marketCap":2937260748},{"date":"2025-02-14","current":-27.514975,"twenty":-20.502574,"median":-13.133203,"eighty":-10.252219,"marketCap":2880487651},{"date":"2025-02-21","current":-48.516252,"twenty":-20.560131,"median":-13.167501,"eighty":-10.2986,"marketCap":2722052854},{"date":"2025-02-28","current":-49.158143,"twenty":-20.593305,"median":-13.217823,"eighty":-10.333405,"marketCap":2758066784},{"date":"2025-03-07","current":-48.248798,"twenty":-20.7725,"median":-13.244155,"eighty":-10.361916,"marketCap":2707047050},{"date":"2025-03-14","current":-47.125489,"twenty":-20.827991,"median":-13.253299,"eighty":-10.387344,"marketCap":2644022673},{"date":"2025-03-21","current":-49.722628,"twenty":-20.996912,"median":-13.351094,"eighty":-10.419218,"marketCap":2789737747},{"date":"2025-03-28","current":-47.039358,"twenty":-21.063827,"median":-13.396707,"eighty":-10.450696,"marketCap":2639190225},{"date":"2025-04-04","current":-43.808483,"twenty":-21.099139,"median":-13.4427,"eighty":-10.499156,"marketCap":2457918720},{"date":"2025-04-11","current":-35.649153,"twenty":-21.227339,"median":-13.476198,"eighty":-10.52564,"marketCap":2000131358},{"date":"2025-04-17","current":-36.689604,"twenty":-21.379018,"median":-13.526174,"eighty":-10.536487,"marketCap":2058506928},{"date":"2025-04-25","current":-39.427634,"twenty":-21.428813,"median":-13.641246,"eighty":-10.581533,"marketCap":2212126848},{"date":"2025-05-02","current":-36.662371,"twenty":-21.486784,"median":-13.659622,"eighty":-10.612849,"marketCap":2056978973},{"date":"2025-05-09","current":-63.739502,"twenty":-21.909087,"median":-13.707761,"eighty":-10.655693,"marketCap":1872220382},{"date":"2025-05-16","current":-62.37665,"twenty":-22.156034,"median":-13.773584,"eighty":-10.681358,"marketCap":1832189354},{"date":"2025-05-23","current":-65.626526,"twenty":-22.263822,"median":-13.839791,"eighty":-10.70252,"marketCap":1927647959},{"date":"2025-05-30","current":-65.102353,"twenty":-22.467817,"median":-13.867401,"eighty":-10.731271,"marketCap":1912251410},{"date":"2025-06-06","current":-62.481485,"twenty":-22.565249,"median":-13.886685,"eighty":-10.75514,"marketCap":1835268664}],"updateTime":1749448088006}}}